SEARCH

SEARCH BY CITATION

References

  • Andriopoulos B Jr, Corradini E, Xia Y, Faasse SA, Chen S, Grgurevic L, Knutson MD, Pietrangelo A, Vukicevic S, Lin HY, Babitt JL (2009) BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat. Genet. 41, 482487.
  • Bachman E, Feng R, Travison T, Li M, Olbina G, Ostland V, Ulloor J, Zhang A, Basaria S, Ganz T, Westerman M, Bhasin S (2010) Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis. J. Clin. Endocrinol. Metab. 95, 47434747.
  • Baggish AL, Hale A, Weiner RB, Lewis GD, Systrom D, Wang F, Wang TJ, Chan SY (2011) Dynamic regulation of circulating microRNA during acute exhaustive exercise and sustained aerobic exercise training. J. Physiol. 589, 39833994.
  • Beran M, Spitzer G, Verma DS (1982) Testosterone and synthetic androgens improve the in vitro survival of human marrow progenitor cells in serum-free suspension cultures. J. Lab. Clin. Med. 99, 247253.
  • Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM (2010) Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 95, 25362559.
  • Casanovas G, Mleczko-Sanecka K, Altamura S, Hentze MW, Muckenthaler MU (2009) Bone morphogenetic protein (BMP)-responsive elements located in the proximal and distal hepcidin promoter are critical for its response to HJV/BMP/SMAD. J. Mol. Med. (Berl). 87, 471480.
  • Chaston T, Chung B, Mascarenhas M, Marks J, Patel B, Srai SK, Sharp P (2008) Evidence for differential effects of hepcidin in macrophages and intestinal epithelial cells. Gut 57, 374382.
  • Coviello AD, Kaplan B, Lakshman KM, Chen T, Singh AB, Bhasin S (2008) Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. J. Clin. Endocrinol. Metab. 93, 914919.
  • Ferrucci L, Maggio M, Bandinelli S, Basaria S, Lauretani F, Ble A, Valenti G, Ershler WB, Guralnik JM, Longo DL (2006) Low testosterone levels and the risk of anemia in older men and women. Arch. Intern. Med. 166, 13801388.
  • Fishbane S, Galgano C, Langley RC Jr, Canfield W, Maesaka JK (1997) Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients. Kidney Int. 52, 217222.
  • Ganz T (2011) Hepcidin and iron regulation, 10 years later. Blood 117, 44254433.
  • Ganz T, Nemeth E (2009) Iron sequestration and anemia of inflammation. Semin. Hematol. 46, 387393.
  • Gordeuk VR, Miasnikova GY, Sergueeva AI, Niu X, Nouraie M, Okhotin DJ, Polyakova LA, Ammosova T, Nekhai S, Ganz T, Prchal JT (2011) Chuvash polycythemia VHLR200W mutation is associated with down-regulation of hepcidin expression. Blood 118, 52785282.
  • Hara N, Nishiyama T, Takizawa I, Saito T, Kitamura Y, Takahashi K (2010) Decline of the red blood cell count in patients receiving androgen deprivation therapy for localized prostate cancer: impact of ADT on insulin-like growth factor-1 and erythropoiesis. Urology 75, 14411445.
  • Jie X, Lang C, Jian Q, Chaoqun L, Dehua Y, Yi S, Yanping J, Luokun X, Qiuping Z, Hui W, Feili G, Boquan J, Youxin J, Jinquan T (2007) Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells. Oncogene 26, 57415751.
  • Kang HY, Huang KE, Chang SY, Ma WL, Lin WJ, Chang C (2002) Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4. J. Biol. Chem. 277, 4374943756.
  • Kautz L, Meynard D, Monnier A, Darnaud V, Bouvet R, Wang RH, Deng C, Vaulont S, Mosser J, Coppin H, Roth MP (2008) Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood 112, 15031509.
  • Kawasaki N, Morimoto K, Tanimoto T, Hayakawa T (1996) Control of hemoglobin synthesis in erythroid differentiating K562 cells. I. Role of iron in erythroid cell heme synthesis. Arch. Biochem. Biophys. 328, 289294.
  • Lainé F, Laviolle B, Ropert M, Bouguen G, Morcet J, Hamon C, Massart C, Westermann M, Deugnier Y, Loréal O (2011) Early effects of erythropoietin on serum hepcidin and serum iron bioavailability in healthy volunteers. Eur. J. Appl. Physiol. 112, 13911397.
  • Mastrogiannaki M, Matak P, Mathieu JR, Delga S, Mayeux P, Vaulont S, Peyssonnaux C (2011) Hepatic hypoxia-inducible factor-2 down-regulates hepcidin expression in mice through an erythropoietin-mediated increase in erythropoiesis. Haematologica 97, 827834.
  • Mirand EA, Murphy GP (1971) Erythropoietin activity in anephric humans given prolonged androgen treatment. J. Surg. Oncol. 3, 5965.
  • Mirand EA, Gordon AS, Wenig J (1965) Mechanism of testosterone action in erythropoiesis. Nature 206, 270272.
  • Moriyama Y, Fisher JW (1975) Effects of testosterone and erythropoietin on erythroid colony formation in human bone marrow cultures. Blood 45, 665670.
  • Pak M, Lopez MA, Gabayan V, Ganz T, Rivera S (2006) Suppression of hepcidin during anemia requires erythropoietic activity. Blood 108, 37303735.
  • Ponka P (1997) Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood 89, 125.
  • Ponka P, Schulman HM (1985) Acquisition of iron from transferrin regulates reticulocyte heme synthesis. J. Biol. Chem. 260, 1471714721.
  • Rebouche CJ, Wilcox CL, Widness JA (2004) Microanalysis of non-heme iron in animal tissues. J. Biochem. Biophys. Methods 58, 239251.
  • Roe MA, Heath AL, Oyston SL, Macrow C, Hoogewerff JA, Foxall R, Dainty JR, Majsak-Newman G, Willis G, Fairweather-Tait SJ (2005) Iron absorption in male C282Y heterozygotes. Am. J. Clin. Nutr. 81, 814821.
  • Roy CN, Mak HH, Akpan I, Losyev G, Zurakowski D, Andrews NC (2007) Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. Blood 109, 40384044.
  • Sasu BJ, Cooke KS, Arvedson TL, Plewa C, Ellison AR, Sheng J, Winters A, Juan T, Li H, Begley CG, Molineux G (2010) Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia. Blood 115, 36163624.
  • Shahidi NT, Diamond LK (1959) Testosterone-induced remission in aplastic anemia. Am. J. Dis. Child. 98, 293302.
  • Silvestri L, Pagani A, Nai A, De Domenico I, Kaplan J, Camaschella C (2008) The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab. 8, 502511.
  • Srivastava RC, Khan S, Shankar U, Pandya KP (1979) Distribution of Fe59 in benzene and iomex treated rats. Arch. Toxicol. 42, 4349.
  • Theurl I, Schroll A, Sonnweber T, Nairz M, Theurl M, Willenbacher W, Eller K, Wolf D, Seifert M, Sun CC, Babitt JL, Hong CC, Menhall T, Gearing P, Lin HY, Weiss G (2011) Pharmacologic inhibition of hepcidin expression reverses anemia of chronic disease in rats. Blood 118, 49774984.
  • Volke M, Gale DP, Maegdefrau U, Schley G, Klanke B, Bosserhoff AK, Maxwell PH, Eckardt KU, Warnecke C (2009) Evidence for a lack of a direct transcriptional suppression of the iron regulatory peptide hepcidin by hypoxia-inducible factors. PLoS One 4, e7875.
  • Watkinson G, McMenemey WH, Evans G (1947) Hypopituitarism, hypogonadism, and anaemia treated with testosterone. Lancet 1, 631633.
  • Yeap BB, Beilin J, Shi Z, Knuiman MW, Olynyk JK, Bruce DG, Milward EA (2009) Serum testosterone levels correlate with haemoglobin in middle-aged and older men. Intern. Med. J. 39, 532538.
  • Yu PB, Hong CC, Sachidanandan C, Babitt JL, Deng DY, Hoyng SA, Lin HY, Bloch KD, Peterson RT (2008) Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat. Chem. Biol. 4, 3341.